Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/04/2001 | WO2001001135A1 Enzyme inhibition immunoassay |
01/04/2001 | WO2001000619A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
01/04/2001 | WO2001000611A1 Respiratory syncytial virus replication inhibitors |
01/04/2001 | WO2001000598A1 N-[4-(6-oxotetrahydrotriazinyl)phenyl]amides and use thereof |
01/04/2001 | WO2001000590A1 Substituted 6-[4-(oxymethyl)-phenyl]-dihydropyridazinones and use thereof |
01/04/2001 | WO2001000589A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof |
01/04/2001 | WO2001000586A1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors |
01/04/2001 | WO2001000584A2 Pyrazolyl derivatives of bicyclic benzoic acids for use as herbicides |
01/04/2001 | WO2001000583A1 Ucf116 derivatives as antitumor agents |
01/04/2001 | WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
01/04/2001 | WO2001000229A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
01/04/2001 | WO2001000213A1 Src kinase inhibitor compounds |
01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
01/04/2001 | WO2000020358B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
01/04/2001 | DE19929783A1 Substituierte 6-[4-(Oxymethyl)-phenyl]-dihydropyridazinone und ihre Verwendung Substituted 6- [4- (oxymethyl) phenyl] -dihydropyridazinone and their use |
01/04/2001 | DE19929782A1 6-Carboxyphenyldihydropyridazinon-Derivate und ihre Verwendung 6-Carboxyphenyldihydropyridazinon derivatives and their use |
01/04/2001 | DE19929781A1 N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung N- [4- (6-Oxotetrahydrotriazinyl) phenyl] amides and their use |
01/04/2001 | CA2383546A1 Src kinase inhibitor compounds |
01/04/2001 | CA2377186A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
01/04/2001 | CA2377117A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof |
01/04/2001 | CA2376781A1 Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors |
01/04/2001 | CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
01/04/2001 | CA2369145A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
01/03/2001 | EP1065206A1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents |
01/03/2001 | EP1065204A1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors |
01/03/2001 | EP1065203A2 Heterocyclic compounds as retinoic acid receptor antagonists |
01/03/2001 | EP1064282A1 Crystalline form of paroxetine |
01/03/2001 | EP1064281A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents |
01/03/2001 | EP0787127B1 5-lipoxygenase inhibitors |
01/03/2001 | EP0708776B1 Antiallergic imidazoazepines |
01/03/2001 | CN1278815A 3-oxo-2(H)-1,2,4-triazine derivativs as ligands of 5HT1A receptors |
01/03/2001 | CN1278810A Substituted benzodihydropyran derivatives |
01/03/2001 | CN1278800A Cyclohexane derivatives difunctionalised in 1.4 as ligands of 5T hia receptors |
01/03/2001 | CN1278798A Trisaryl-1,3,5-triazine ultraviolet light absorbers |
01/03/2001 | CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors |
01/03/2001 | CN1278793A Sulfonyl derivatives |
01/03/2001 | CN1278790A Chemical compound |
01/03/2001 | CN1278725A Indeno [1,2-c]-naphtho [1,2-C]- and benzo [6,7] cyclohepta [1,2-C] pyrazole derivatives |
01/03/2001 | CN1060168C Xanthene derivant, its preparation method and medicinal composition containing same |
01/02/2001 | US6169188 Treating cyclooxygenase-2 mediated diseases |
01/02/2001 | US6169181 Compounds useful to treat retroviral infections |
01/02/2001 | US6169097 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives |
01/02/2001 | US6169096 For inhibiting tumor growth in a mammal |
01/02/2001 | US6169093 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia |
01/02/2001 | US6169088 1,3 diazines with platelet-derived growth factor receptor inhibitory activity |
01/02/2001 | CA2161662C Process for preparing intermediates for the synthesis of antifungal agent |
01/02/2001 | CA1341162C Sbustituted aminomethyltetralins and their heterocyclic analogues |
01/02/2001 | CA1341161C Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them |
01/02/2001 | CA1341159C Pure enantiomers of 4,5-disubstituted .alpha.-butyrolactams, process for their preparation, and their use |
12/28/2000 | WO2000078757A1 Inhibitors of il-12 production |
12/28/2000 | WO2000078756A1 Thiophene-ethyl thiourea compounds and their use in the treatment of hiv |
12/28/2000 | WO2000078755A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
12/28/2000 | WO2000078753A1 Process for the preparation of paroxetine and structurally related compounds |
12/28/2000 | WO2000078752A1 Process for the production of paroxetine hydrochloride |
12/28/2000 | WO2000078751A2 Compounds for use in treatment of neurological disorders |
12/28/2000 | WO2000078747A1 Acylhydrazine derivatives, process for preparing the same and use thereof |
12/28/2000 | WO2000078744A1 Thiochroman derivatives against neurological disorders |
12/28/2000 | WO2000078742A1 Chroman derivatives against neurological disorders |
12/28/2000 | WO2000078735A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
12/28/2000 | WO2000078733A1 Phenoxy fluoropyrimidines |
12/28/2000 | WO2000078732A1 Halopyrimidines |
12/28/2000 | WO2000078728A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
12/28/2000 | WO2000078726A1 Imidazoline derivatives for the treatment of diabetes, especially type ii diabetes |
12/28/2000 | WO2000078725A1 Synthesis of substituted amidines |
12/28/2000 | WO2000078724A2 Imidazolinderivatives their preparation and their pharmaceutical use |
12/28/2000 | WO2000078718A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans |
12/28/2000 | WO2000078716A1 α1B-ADRENERGIC RECEPTOR ANTAGONISTS |
12/28/2000 | WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands |
12/28/2000 | WO2000049021A3 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
12/28/2000 | WO2000047584A3 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals |
12/28/2000 | WO2000044379B1 Methods for restoring and/or enhancing accommodation in pseudo phakia |
12/28/2000 | WO2000043373A3 Kinase inhibitors |
12/28/2000 | WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors |
12/28/2000 | DE19928306A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases |
12/28/2000 | CA2383492A1 Acylhydrazine derivatives, their production and use |
12/28/2000 | CA2375261A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
12/28/2000 | CA2373921A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
12/28/2000 | CA2341542A1 .alpha.1b-adrenergic receptor antagonists |
12/27/2000 | EP1063235A1 Benzofurylpyrone derivatives |
12/27/2000 | EP1062216A1 Inhibitors of phospholipase a2 |
12/27/2000 | EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
12/27/2000 | EP1062206A2 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis |
12/27/2000 | EP1062205A2 Inhibitors of phospholipase enzymes |
12/27/2000 | EP1061936A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders |
12/27/2000 | EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
12/27/2000 | CN1278256A Ureido and thioureido derivatives of 4-amino-2-(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents |
12/27/2000 | CN1278250A Vitronectin receptor antagonists |
12/27/2000 | CN1278244A Dipeptide nitriles |
12/27/2000 | CN1278175A Compositions of lipid lowering agents |
12/27/2000 | CN1277962A Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same |
12/27/2000 | CN1059898C Piperidine derivatives, prepn. method and use thereof |
12/26/2000 | US6166222 Reacting a pyrrolecarboxylic acid derivative in ammonia with an alkali metal or alkaline earth metal and then an aqueos salt solution of a alkyl- or silyl-leaving group compound |
12/26/2000 | US6166219 Treatment of diabetes and related disorders |
12/26/2000 | US6166060 Antihistamines; sleep disorders; central nervous system disorders |
12/26/2000 | US6166059 Thiocyano- triazolyl derivatives and their use as microbicides |
12/26/2000 | US6166037 A blocking agent for blocking the entry of hiv into target cells of a patient to prevent infection of the patient by hiv |
12/26/2000 | US6166028 Diaminopuridine-containing thiourea inhibitors of herpes viruses |
12/26/2000 | US6166027 Treatment of high blood pressure and cardiac insufficiency, angina pectoris, arrhythmias, thromboembolic diseases, ischaemias, myocardial infarction, cerebral stroke, restenoses, coronary angioplasties, arteriosclerosis |
12/26/2000 | US6166023 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments |
12/26/2000 | US6166018 For treating fungal infection wherein said fungal infection is central candidiasis |